Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy

Auteurs

Angelina Tjokrowidjaja, Michael Friedlander, Sarah J. Lord, Rebecca Asher, Manuel Rodrigues, Jonathan A. Ledermann, Ursula A. Matulonis, Amit M. Oza, Ilan Bruchim, Tomasz Huzarski, Charlie Gourley, Philipp Harter, Ignace Vergote, Clare L. Scott, Werner Meier, Ronnie Shapira-Frommer, Tsveta Milenkova, Eric Pujade-Lauraine, Val Gebski, Chee K. Lee